Shuttle Pharmaceuticals gets Nasdaq notice after missing 10-Q filing deadline

RegulatoryNegative

AI Analysis

Summary

Shuttle Pharmaceuticals received a Nasdaq notice after failing to meet its 10-Q filing deadline, a regulatory compliance issue that may affect its listing status.

Outcome Details

Nasdaq notice for missing 10-Q filing deadline

Importance:6/10

Sentiment:

-0.80

complianceregulatorynasdaqsecfiling

Related Companies

$SHPH

Read the original article

Published by Seeking Alpha Healthcare on August 28, 2026 8:17 PM

Read Original